References
- 1. Stefanovic V, Cukuranovic Rade, Miljkovic Sladjana, Marinkovica Dragoslav, Toncheva Draga. Fifty years of Balkan endemic nephropathy: Challenges of study using epidemiological methods. Renal Failure. 2009; 31(5): 409-418.
- 2. Toncheva D, Dimitrov Tz. Genetic predisposition to Balkan endemic nephropathy. Nephron 1996, 72, 564-569.
- 3. Stefanovic V, Toncheva D, Atanasova S, Polenakovic M. Etiology of Balkan Endemic Nephropathy and associated urothelial cancer. Am J Nephrol. 2006; 26(1): 1-11.
- 4. Zaharieva B, Stock C, Ambros P, Dimitrov Tz, Toncheva D.: First report on cytogenetic changes in an uroepithelial tumor of a patient with Balkan Endemic Nephropathy. BJMG. 1999; 2(3): 35-37.
- 5. Toncheva D.I, Atanassova S, Gergov Tz.D, Todorovska E.G, Roeva I.G, Georgiev Tch., et al. Genetic changes in uroepithelial tumors of patients with Balkan Endemic Nephropathy. Journal of Nephrology. 2002; 15(4): 387-393.
- 6. Toncheva D, Dimitrov Tz, Stojanova St. Etiology of Balkan endemic nephropathy: A multifactorial disease? Eur J of Epidemiology. 1998; 14: 389-394.
- 7. Galabov A, Kamarinchev B, Toncheva D, Stoitsova S, Dimitrov Tz. Are viruses causative agents of the Balkan Endemic Nephropathy. Proceedings Tenth Congress of the Bulgarian Microbiologists with International Participation. Plovdiv, October 9-12, 2002.
- 8. Toncheva D, Dimitrov Tz, Tzoneva M. Cytogenetic study in Balkan endemic nephropathy. Nephron. 1988; 48: 18-21.
- 9. Toncheva D.I, Gergov T.D, Tzoneva M.T, Bouchakliev Z.P. Spontaneous and induced chromosome aberrations in Balkan endemic nephropathy. Kidney International. 1991; 40 (SUPPL. 34): S-97-101.
- 10. Atanassova S, Dimitrova A, Dimitrov Tz, Kaneva R, Kremenski I, Toncheva D. Comparative study of CYP2D6 gene polymorphism in healthy Bulgarian population and patients with Balkan endemic nephropathy. BJMG. 2000; 3(3): 27-30.
- 11. Atanasova SY, Ahsen N von, Toncheva DI, Dimitrov TG, Oellerich M, Armstrong VW. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin Biochem. 2005; 38(3): 223-228.
- 12. Atanasova S, Ahsen N von, Tz. Dimitrov, M. Oellerich, D. Toncheva: First study of NAT1 and NAT2 polymorphisms in Bulgarian patients with Balkan endemic nephropathy (BEN) and healthy controls. Biotechnol. & Biotechnol. Eq. 2004; 18(1): 95-103.
- 13. Atanasova S, Ahsen N von, Dimitrov Tz, Armstrong V, Oellerich M, Toncheva D. Real time polymerase chain reaction for genotyping of the transforming grow factor β1 polymorphism Thr263Ile in patients with Balkan endemic nephropathy and in a healthy Bulgarian population. BJMG. 2002; 5 (3&4): 37-40.
- 14. Toncheva D, Ahsen N. von, Atanasova S, Dimitrov Tz, Armstrong V, Oellerich M. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol. 2004; 17: 384-389.
- 15. Atanasova S, Ahsen N. von, Dimitrov Tz, Armstrong V, Oellerich M, Toncheva D. MDR1 haplotypes modify BEN disease risk: A study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls. Nephron Exp Nephrol. 2004; 96(1),e7 - e13, DOI: 10.1159/000075571
- 16. Mantle P, Modalca Mirela, Nicholls Andrew, Tatu Calin, Tatu Diana and Toncheva Draga. Comparative 1H NMR metabolomic urinalysis of people diagnosed with Balkan endemic nephropathy, and healthy subjects, in Romania and Bulgaria: a pilot study. Toxins. 2011; 3: 815-833.
- 17. Toncheva D, Galabov A, Laich A, Atanassova S, Kamarinchev B, Dimitrov Tz, Fuchs D. Urinary neopterin concentration in patients with Balkan endemic nephropathy. Kidney Int. 2003; 64: 1817-1821.
- 18. Toncheva D, Mihailova-Hristova M, Vazharova R, Staneva R, Karachanak S, Dimitrov P, et. al. NGS nominated CELA1, HSPG2 and KCNK5 as candida te-genes for predisposition to Balkan Endemic Nephropathy. BioMed Res Int. 2014; 1-7, doi: 10.1155/2014/920723
- 19. Shen, L, et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet. 2007; 3(10): p. 2023-36.
- 20. Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006; 114(3): p. A160-7.
- 21. Bjornsson H.T, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA, 2008; 299(24): p. 2877-83.
- 22. Wolfe K.H. and W.-H. Li, Molecular evolution meets the genomics revolution. Nat Genet.
- 23. Esteller M, and Herman J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. The Journal of Pathology. 2002; 196(1): p. 1-7.
- 24. Kulis M. and Esteller M. 2 - DNA Methylation and Cancer, in Advances in Genetics, H. Zdenko and U. Toshikazu, Editors. 2010, Academic Press. p. 27-56.
- 25. Das P.M. and Singal R. DNA methylation and cancer. J Clin Oncol. 2004; 22(22): p. 4632-42.
- 26. Richardson B. DNA methylation and autoimmune disease. Clinical Immunology. 2003; 109(1): p. 72-79.
- 27. Stefanovic Vladisav, Jelakovic Bojan, Cukuranovic Rade, Bukvic Dana, Nikolic Jovan, Lukic Ljiljana, et al. Diagnostic criteria for Balkan endemic nephropathy: proposal by an international panel. Renal Failure. 2007; 29(7): p. 867-80.
- 28. Staneva Rada, Blaga G, Rukova B, Hadjidekova Savina, Nesheva Desislava, Antonova Olga, et al. Whole genome methylation array analysis reveals new aspects in Balkan Endemic Nephropathy etiology. BMC Nephrol. 2013; 14: 225.